3-Amino-3-(5-hydroxy-4-oxopyran-3-yl)propanenitrile

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡喃
• 英文名称: 3-Amino-3-(5-hydroxy-4-oxopyran-3-yl)propanenitrile
• 英文别名: 3-amino-3-(5-hydroxy-4-oxopyran-3-yl)propanenitrile
• 化学式: C₈H₈N₂O₃
• 分子量: 180.16
• InChiKey: WCULZMLGOVYOMJ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.9
• 重原子数：
  13
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  96.3
• 氢给体数：
  2
• 氢受体数：
  5

文献信息

• [EN] CYSTATHIONINE-Y-GAMMA-LYASE (CSE) INHIBITORS<br/>[FR] INHIBITEURS DE LA CYSTATHIONINE-Y-GAMMA-LYASE (CSE)
  申请人：SOVA PHARMACEUTICALS INC

  公开号：WO2014018569A1

  公开（公告）日：2014-01-30

  Described herein are compounds and pharmaceutical compositions containing such compounds which inhibit cystathionine-γ- lyase (CSE). Also described herein are methods for using such CSE inhibitors, alone or in combination with other compounds, for treating diseases or conditions that would benefit from CSE inhibition.

  本文描述了抑制半胱氨酸-γ-裂解酶（CSE）的化合物和含有这些化合物的药物组合物。本文还描述了使用这些CSE抑制剂的方法，单独或与其他化合物结合，用于治疗需要CSE抑制的疾病或症状。
• CYSTATHIONINE-GAMMA-LYASE (CSE) INHIBITORS
  申请人：SOVA PHARMACEUTICALS, INC.

  公开号：US20150175561A1

  公开（公告）日：2015-06-25

  Described herein are compounds and pharmaceutical compositions containing such compounds which inhibit cystathionine-γ-lyase (CSE). Also described herein are methods for using such CSE inhibitors, alone or in combination with other compounds, for treating diseases or conditions that would benefit from CSE inhibition.

  本文描述了一些抑制半胱氨酸-γ-裂解酶（CSE）的化合物和含有这些化合物的药物组合物。本文还描述了使用这些CSE抑制剂的方法，单独或与其他化合物结合，用于治疗需要CSE抑制的疾病或病症。
• USE OF CSE INHIBITORS FOR THE TREATMENT OF CUTANEOUS INJURIES OR CONDITIONS AND SLEEP-RELATED BREATHING DISORDERS
  申请人：SOVA PHARMACEUTICALS, INC.

  公开号：US20150272934A1

  公开（公告）日：2015-10-01

  Described are methods of treatment of cutaneous injuries or conditions comprising administration of CSE inhibitors to individuals in need thereof. Also described herein are methods of treatment of sleep-related breathing disorders comprising administration of CSE inhibitors to individuals in need thereof.

  本文描述了治疗皮肤损伤或疾病的方法，包括向需要此类治疗的个体投药CSE抑制剂。此外，本文还描述了治疗睡眠相关呼吸障碍的方法，包括向需要此类治疗的个体投药CSE抑制剂。
• Cystathionine-gamma-lyase (CSE) inhibitors
  申请人：Sova Pharmaceuticals, Inc.

  公开号：US10227314B2

  公开（公告）日：2019-03-12

  Described herein are compounds and pharmaceutical compositions containing such compounds which inhibit cystathionine-γ-lyase (CSE). Also described herein are methods for using such CSE inhibitors, alone or in combination with other compounds, for treating diseases or conditions that would benefit from CSE inhibition.

  本文描述了抑制胱硫醚-γ-赖氨酸酶（CSE）的化合物和含有此类化合物的药物组合物。本文还描述了使用此类 CSE 抑制剂（单独使用或与其他化合物联合使用）治疗可从 CSE 抑制中获益的疾病或病症的方法。
• [EN] USE OF CSE INHIBITORS FOR THE TREATMENT OF CUTANEOUS INJURIES OR CONDITIONS AND SLEEP-RELATED BREATHING DISORDERS<br/>[FR] UTILISATION D'INHIBITEURS DE CSE POUR LE TRAITEMENT DE LÉSIONS OU D'AFFECTIONS CUTANÉES ET DE TROUBLES RESPIRATOIRES DU SOMMEIL
  申请人：SOVA PHARMACEUTICALS INC

  公开号：WO2014018571A2

  公开（公告）日：2014-01-30